| GENERAL INFORMATION | |||
|---|---|---|---|
| Company name: | Greenlight Biosciences España, S.L. | ||
| Address: | Carretera Nacional IV, KM 566, 41720 Los Palacios Y Villafranca , Spain | ||
| Web: | https://www.greenlightbiosciences.com/ | ||
| Company creation date: | 2022 | ||
| Employees: | 133 | ||
| Field of activity: | Veterinary | ||
| Record last updated on: | 14/06/2024 | ||
| CONTACT DETAILS | |||
| Contact name: | |||
| Tel: | |||
| Email: | |||
| COMPANY SECTOR | |||
| (Bio)Pharmaceutical: | |||
| Early manufacturing/Research&Discovery stage: | |||
| Development stage: | |||
| Commercialisation/Marketing stage (EU/Non-EU): | |||
| Medical Device and Technology: | |||
| Development stage: | |||
| Commercialisation/Marketing stage (EU/Non-EU): | |||
| PRODUCT INFORMATION | |||
| Medicinal Products | |||
| Vaccines: | |||
| Therapeutic medicines: | |||
| Diagnostic and imaging products: | |||
| Combined medicinal products and devices: | |||
| Product Development Stages | Number of Products |
||
| Research/Discovery: | |||
| Pharmaceutical development: | |||
| Preclinical: | |||
| Clinical exploratory: | |||
| Clinical confirmatory: | |||
| (Pre)registration (EU/Non-EU): | |||
| Marketing (EU/Non-EU): | |||
| SUBSTANCES | |||
| Chemical entities | |||
| Single entities | |||
| Combinations of single entities | |||
| Peptides (chemically synthesised) | |||
| Biologically derived proteins and peptides | |||
| Monoclonal antibodies | |||
| Recombinant proteins | |||
| Extracted proteins | |||
| Nucleic Acids (chemically synthesised/biologically derived) | |||
| RNA | |||
| DNA | |||
| Polymer (natural and synthetic - excluding peptides, proteins and nucleic acids) | |||
| Homopolymers | |||
| Copolymers | |||
| Advanced therapy medicinal products | |||
| Somatic cell therapy products | |||
| Tissue engineered products | |||
| Gene therapy products | |||
| Radionuclides | |||
| Allergens | |||
| Polyclonal immunoglobulins | |||
| Herbal derived complex substances | |||
| Animal derived complex substances | |||
| Other | |||
| SPECIFIC CATEGORIES | |||
| Artificial intelligence, big data, software as medical device, digital health/medicines | |||
| Biodefense | |||
| Biosimilars | |||
| Excipients | |||
| Foods (functional foods, nutraceuticals) | |||
| Generics | |||
| Genetically modified organisms (GMOs) | |||
| Homeopathics | |||
| Maximum residue limits (veterinary medicines) | |||
| Medicines for tropical diseases | |||
| MUMS (‘Minor Use/Minor species’)/Limited market (veterinary medicines) | |||
| Nanotechnology (including e.g. microparticles, liposomes, microbeads) | |||
| New formulations/delivery methods | |||
| Orphan medicines | |||
| OTC (over the counter)/non-prescription/self-medication | |||
| Paediatric medicines | |||
| Personalised/targeted products, biomarkers, pharmacogenomics, precision medicines, companion diagnostics | |||
| Stem cells | |||
| Transgenic technology | |||
| Other | THERAPEUTIC AREA | ||
| A Alimentary tract and metabolism | |||
| B Blood and blood forming organs | |||
| C Cardiovascular system | |||
| D Dermatologicals | |||
| G Genito-urinary system and sex hormones | |||
| H Systemic hormonal preparations, excluding sex hormones | |||
| J General anti-infectives for systemic use | |||
| L Anti-neoplastic and immunomodulating agents | |||
| M Musculo-skeletal system | |||
| N Nervous system | |||
| P Anti-parasitic products, Insecticides, Repellents | |||
| R Respiratory system | |||
| S Sensory organs | |||
| V Various | |||
| Back to list | |||